Presenilin-1 regulates induction of hypoxia inducible factor-1α: Altered activation by a mutation associated with familial Alzheimer's disease

Molecular Neurodegeneration

Volumn 5, Issue 1, 2010, Pages

  De Gasperi, Rita ^a,b   Sosa, Miguel A Gama ^a,b   Dracheva, Stella ^a,b   Elder, Gregory A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT CHLORIDE; GAMMA SECRETASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSULIN; INSULIN RECEPTOR; LENTIVIRUS VECTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PRESENILIN 1; PROTEASOME; PROTEIN KINASE B;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHELATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FAMILIAL DISEASE; FIBROBLAST; GENE MUTATION; HYPOXIA; MOUSE; NERVE CELL; NONHUMAN; PROTEIN DEGRADATION; PROTEIN INTERACTION; REGULATORY MECHANISM; WESTERN BLOTTING;

EID: 77956884129     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-5-38     Document Type: Article

References (89)

1. Alzheimer's disease: genes, proteins, and therapy. DJ Selkoe, Physiol Rev 2001 81 2 741 766 11274343
2. Genetics of Alzheimer's disease: a centennial review. N Ertekin-Taner, Neurol Clin 2007 25 3 611 667 10.1016/j.ncl.2007.03.009 17659183
3. Alzheimer Disease & Frontotemporal Dementia Mutation Database. http://www.molgen.ua.ac.be/ADMutations
4. Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations. A Lleo O Berezovska JH Growdon BT Hyman, Am J Geriatr Psychiatry 2004 12 2 146 156 15010344
5. A beta oligomers - a decade of discovery. DM Walsh DJ Selkoe, J Neurochem 2007 101 5 1172 1184 10.1111/j.1471-4159.2006.04426.x 17286590
6. Interventions for heart disease and their effects on Alzheimer's disease. B Wolozin MM Bednar, Neurol Res 2006 28 6 630 636 10.1179/016164106X130515 16945215
7. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. DA Snowdon LH Greiner JA Mortimer KP Riley PA Greiner WR Markesbery, Jama 1997 277 10 813 817 10.1001/jama.277.10.813 9052711
8. Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain. RN Kalaria SU Bhatti EA Palatinsky DH Pennington ER Shelton HW Chan G Perry WD Lust, Neuroreport 1993 4 2 211 214 10.1097/00001756- 199302000-00025 8453062 (Pubitemid 23080879)
9. Expression of beta-amyloid precursor protein mRNAs following transient focal ischaemia. J Koistinaho I Pyykonen R Keinanen T Hokfelt, Neuroreport 1996 7 15-17 2727 2731 10.1097/00001756-199611040-00064 8981456
10. Progressive parenchymal deposition of beta-amyloid precursor protein in rat brain following global cerebral ischemia. B Lin R Schmidt-Kastner R Busto MD Ginsberg, Acta Neuropathol (Berl) 1999 97 4 359 368 10.1007/s004010050999 (Pubitemid 29134516)
11. Altered processing of amyloid precursor protein in the human neuroblastoma SH-SY5Y by chronic hypoxia. NJ Webster KN Green C Peers PF Vaughan, J Neurochem 2002 83 6 1262 1271 10.1046/j.1471-4159.2002.01236.x 12472881
12. Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection. GJ Chen J Xu SA Lahousse NL Caggiano SM de la Monte, J Alzheimers Dis 2003 5 3 209 228 12897406
13. Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP. L Li X Zhang D Yang G Luo S Chen W Le, Neurobiol Aging 2009 30 7 1091 1098 10.1016/j.neurobiolaging.2007.10.011 18063223
14. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. X Sun G He H Qing W Zhou F Dobie F Cai M Staufenbiel LE Huang W Song, Proc Natl Acad Sci USA 2006 103 49 18727 18732 10.1073/pnas.0606298103 17121991
15. Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. X Zhang K Zhou R Wang J Cui SA Lipton FF Liao H Xu YW Zhang, J Biol Chem 2007 282 15 10873 10880 10.1074/jbc.M608856200 17303576
16. Targeting HIF-1 for cancer therapy. GL Semenza, Nat Rev Cancer 2003 3 10 721 732 10.1038/nrc1187 13130303
17. Hypoxia-inducible factor-1 (HIF-1). Q Ke M Costa, Mol Pharmacol 2006 70 5 1469 1480 10.1124/mol.106.027029 16887934
18. Signal transduction to hypoxia-inducible factor 1. G Semenza, Biochem Pharmacol 2002 64 5-6 993 998 10.1016/S0006-2952(02)01168-1 12213597
19. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. C Treins S Giorgetti-Peraldi J Murdaca GL Semenza E Van Obberghen, J Biol Chem 2002 277 31 27975 27981 10.1074/jbc.M204152200 12032158
20. Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway. DP Stiehl W Jelkmann RH Wenger T Hellwig-Burgel, FEBS Lett 2002 512 1-3 157 162 10.1016/S0014-5793(02)02247-0 11852072
21. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. R Fukuda K Hirota F Fan YD Jung LM Ellis GL Semenza, J Biol Chem 2002 277 41 38205 38211 10.1074/jbc.M203781200 12149254
22. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. E Zelzer Y Levy C Kahana BZ Shilo M Rubinstein B Cohen, Embo J 1998 17 17 5085 5094 10.1093/emboj/17.17.5085 9724644
23. Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling. G Doronzo I Russo L Mattiello C Riganti G Anfossi M Trovati, Diabetologia 2006 49 5 1049 1063 10.1007/s00125-006-0156-0 16506055
24. Presenilin-2 (PS2) expression up-regulation in a model of retinopathy of prematurity and pathoangiogenesis. WJ Lukiw WC Gordon EI Rogaev H Thompson NG Bazan, Neuroreport 2001 12 1 53 57 10.1097/00001756-200101220-00019 11201091
25. Presenilins in the heart: presenilin-2 expression is increased by low glucose and by hypoxia in cardiac cells. D Mohuczy K Qian MI Phillips, Regul Pept 2002 110 1 1 7 10.1016/S0167-0115(02)00225-2 12468103
26. Altered expression of cyclooxygenase-2, presenilins and oxygen radical scavenging enzymes in a rat model of global perinatal asphyxia. P Piscopo A Bernardo G Calamandrei A Venerosi A Valanzano D Bianchi A Confaloni L Minghetti, Exp Neurol 2008 209 1 192 198 10.1016/j.expneurol.2007.09.014 17963755
27. PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. L Baki J Shioi P Wen Z Shao A Schwarzman M Gama-Sosa R Neve NK Robakis, Embo J 2004 23 13 2586 2596 10.1038/sj.emboj.7600251 15192701
28. Presenilins mediate phosphatidylinositol 3-kinase/AKT and ERK activation via select signaling receptors. Selectivity of PS2 in platelet-derived growth factor signaling. DE Kang IS Yoon E Repetto T Busse N Yermian L Ie EH Koo, J Biol Chem 2005 280 36 31537 31547 10.1074/jbc.M500833200 16014629
29. Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. CC Weihl GD Ghadge SG Kennedy N Hay RJ Miller RP Roos, J Neurosci 1999 19 13 5360 5369 10377346
30. Potential roles for presenilin-1 in oxygen sensing and in glial-specific gene expression. JG Cui PE Fraser P St George-Hyslop D Westaway WJ Lukiw, Neuroreport 2004 15 13 2025 2028 10.1097/00001756-200409150-00006 15486475
31. Differential display analysis of presenilin 1-deficient mouse brains. J Liauw V Nguyen J Huang P St George-Hyslop R Rozmahel, Mol Brain Res 2002 109 1-2 56 62 10.1016/S0169-328X(02)00491-6 12531515
32. HIF-1: an oxygen and metal responsive transcription factor. P Maxwell K Salnikow, Cancer Biol Ther 2004 3 1 29 35 14726713
33. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. MA Dery MD Michaud DE Richard, Int J Biochem Cell Biol 2005 37 3 535 540 10.1016/j.biocel.2004.08.012 15618010
34. Regulation of hypoxia-inducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I. C Treins S Giorgetti-Peraldi J Murdaca MN Monthouel-Kartmann E Van Obberghen, Mol Endocrinol 2005 19 5 1304 1317 10.1210/me.2004-0239 15695372
35. Chelation of cellular calcium modulates hypoxia-inducible gene expression through activation of hypoxia-inducible factor-1alpha. U Berchner-Pfannschmidt F Petrat K Doege B Trinidad P Freitag E Metzen H de Groot J Fandrey, J Biol Chem 2004 279 43 44976 44986 10.1074/jbc.M313995200 15322093
36. Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration. EH Koo R Kopan, Nat Med 2004 10 Suppl 26 33 10.1038/nm1065 15272268
37. Generation of intracellular domain of insulin receptor tyrosine kinase by gamma-secretase. K Kasuga H Kaneko M Nishizawa O Onodera T Ikeuchi, Biochem Biophys Res Commun 2007 360 1 90 96 10.1016/j.bbrc.2007.06.022 17577576
38. The insulin-like growth factor 1 (IGF-1) receptor is a substrate for gamma-secretase-mediated intramembrane proteolysis. B McElroy JC Powell JV McCarthy, Biochem Biophys Res Commun 2007 358 4 1136 1141 10.1016/j.bbrc.2007. 05.062 17524361
39. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. P Marambaud PH Wen A Dutt J Shioi A Takashima R Siman NK Robakis, Cell 2003 114 5 635 645 10.1016/j.cell.2003.08.008 13678586
40. Regulation of insulin receptor function. JF Youngren, Cell Mol Life Sci 2007 64 7-8 873 891 10.1007/s00018-007-6359-9 17347799
41. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. GL Wang BH Jiang EA Rue GL Semenza, Proc Natl Acad Sci USA 1995 92 12 5510 5514 10.1073/pnas.92.12.5510 7539918
42. The role of presenilin and its interacting proteins in the biogenesis of Alzheimer's beta amyloid. G Verdile SE Gandy RN Martins, Neurochem Res 2007 32 4-5 609 623 10.1007/s11064-006-9131-x 16944319
43. Presenilin modulates Pen-2 levels posttranslationally by protecting it from proteasomal degradation. AS Crystal VA Morais RR Fortna D Carlin TC Pierson CA Wilson VM Lee RW Doms, Biochemistry 2004 43 12 3555 3563 10.1021/bi0361214 15035625
44. When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease. MS Wolfe, EMBO Rep 2007 8 2 136 140 10.1038/sj.embor.7400896 17268504
45. Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease. B De Strooper, EMBO Rep 2007 8 2 141 146 10.1038/sj.embor.7400897 17268505
46. Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations. MA Gama Sosa RD Gasperi AB Rocher AC Wang WG Janssen T Flores GM Perez J Schmeidler DL Dickstein PR Hof, et al. Am J Pathol 2010 176 1 353 368 10.2353/ajpath.2010.090482 20008141
47. Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. YM Lee CH Jeong SY Koo MJ Son HS Song SK Bae JA Raleigh HY Chung MA Yoo KW Kim, Dev Dyn 2001 220 2 175 186 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F 11169851
48. Pathological and physiological functions of presenilins. KS Vetrivel YW Zhang H Xu G Thinakaran, Mol Neurodegener 2006 1 4 10.1186/1750-1326-1-4 16930451
49. HIF1 and oxygen sensing in the brain. FR Sharp M Bernaudin, Nat Rev Neurosci 2004 5 6 437 448 10.1038/nrn1408 15152194
50. The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. RJ Kewley ML Whitelaw A Chapman-Smith, Int J Biochem Cell Biol 2004 36 2 189 204 10.1016/S1357-2725(03)00211-5 14643885
51. Presenilin 1 is actively degraded by the 26 S proteasome. PE Fraser G Levesque G Yu LR Mills J Thirlwell M Frantseva SE Gandy M Seeger PL Carlen P St George-Hyslop, Neurobiol Aging 1998 19 1 Suppl 19 21 10.1016/S0197-4580(98) 00029-3 9562462
52. Dual roles of proteasome in the metabolism of presenilin 1. T Honda K Yasutake N Nihonmatsu M Mercken H Takahashi O Murayama M Murayama K Sato A Omori S Tsubuki, et al. J Neurochem 1999 72 1 255 261 10.1046/j.1471-4159.1999. 0720255.x 9886077
53. Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. AL Mah G Perry MA Smith MJ Monteiro, J Cell Biol 2000 151 4 847 862 10.1083/jcb.151.4.847 11076969
54. Overexpression of ubiquilin decreases ubiquitination and degradation of presenilin proteins. LK Massey AL Mah DL Ford J Miller J Liang H Doong MJ Monteiro, J Alzheimers Dis 2004 6 1 79 92 15004330
55. Ubiquilin regulates presenilin endoproteolysis and modulates gamma-secretase components, Pen-2 and nicastrin. LK Massey AL Mah MJ Monteiro, Biochem J 2005 391 Pt 3 513 525 15975090
56. Glucose and endoplasmic reticulum calcium channels regulate HIF-1beta via presenilin in pancreatic beta-cells. V Dror TB Kalynyak Y Bychkivska MH Frey M Tee KD Jeffrey V Nguyen DS Luciani JD Johnson, J Biol Chem 2008 283 15 9909 9916 10.1074/jbc.M710601200 18174159
57. Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. JW Unger JN Livingston AM Moss, Prog Neurobiol 1991 36 5 343 362 10.1016/0301-0082(91)90015-S 1887067
58. Insulin and neurodegenerative disease: shared and specific mechanisms. S Craft GS Watson, Lancet Neurol 2004 3 3 169 178 10.1016/S1474-4422(04)00681-7 14980532
59. Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair. TJ Nelson MK Sun J Hongpaisan DL Alkon, Eur J Pharmacol 2008 585 1 76 87 10.1016/j.ejphar.2008.01.051 18402935
60. Signaling by insulin-like growth factor 1 in brain. CA Bondy CM Cheng, Eur J Pharmacol 2004 490 1-3 25 31 10.1016/j.ejphar.2004.02.042 15094071
61. Insulin and insulin-like growth factor I signalling in neurons. D Davila J Piriz JL Trejo A Nunez I Torres-Aleman, Front Biosci 2007 12 3194 3202 10.2741/2306 17485293
62. Aging of the brain, neurotrophin signaling, and Alzheimer's disease: is IGF1-R the common culprit? L Puglielli, Neurobiol Aging 2008 29 6 795 811 10.1016/j.neurobiolaging.2007.01.010 17313996
63. Insulin-like growth factor-1 in plasma and brain: regulation in health and disease. C Sievers HJ Schneider GK Stalla, Front Biosci 2008 13 85 99 10.2741/2662 17981530
64. Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective. JA Luchsinger, Eur J Pharmacol 2008 585 1 119 129 10.1016/j.ejphar.2008.02.048 18384771
65. Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology. MS Beeri JM Silverman KL Davis D Marin HZ Grossman J Schmeidler DP Purohit DP Perl M Davidson RC Mohs, et al. J Gerontol A Biol Sci Med Sci 2005 60 4 471 475 15933386
66. Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology. MS Beeri J Schmeidler JM Silverman S Gandy M Wysocki CM Hannigan DP Purohit G Lesser HT Grossman V Haroutunian, Neurology 2008 71 10 750 757 10.1212/01.wnl.0000324925.95210.6d 18765651
67. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. L Gasparini GK Gouras R Wang RS Gross MF Beal P Greengard H Xu, J Neurosci 2001 21 8 2561 2570 11306609
68. IGF-1-induced processing of the amyloid precursor protein family is mediated by different signaling pathways. L Adlerz S Holback G Multhaup K Iverfeldt, J Biol Chem 2007 282 14 10203 10209 10.1074/jbc.M611183200 17301053
69. Insulin increases CSF Abeta42 levels in normal older adults. GS Watson ER Peskind S Asthana K Purganan C Wait D Chapman MW Schwartz S Plymate S Craft, Neurology 2003 60 12 1899 1903 12821730
70. Differential modulation of plasma beta-amyloid by insulin in patients with Alzheimer disease. JJ Kulstad PS Green DG Cook GS Watson MA Reger LD Baker SR Plymate S Asthana K Rhoads PD Mehta, et al. Neurology 2006 66 10 1506 1510 10.1212/01.wnl.0000216274.58185.09 16717209
71. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. MA Reger GS Watson PS Green LD Baker B Cholerton MA Fishel SR Plymate MM Cherrier GD Schellenberg WH Frey, et al. J Alzheimers Dis 2008 13 3 323 331 18430999
72. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. MA Reger GS Watson PS Green CW Wilkinson LD Baker B Cholerton MA Fishel SR Plymate JC Breitner W DeGroodt, et al. Neurology 2008 70 6 440 448 10.1212/01.WNL.0000265401.62434.36 17942819
73. Serum insulin-like growth factor I regulates brain amyloid-beta levels. E Carro JL Trejo T Gomez-Isla D LeRoith I Torres-Aleman, Nat Med 2002 8 12 1390 1397 10.1038/nm793 12415260
74. Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis. E Carro JL Trejo A Gerber H Loetscher J Torrado F Metzger I Torres-Aleman, Neurobiol Aging 2006 29 9 1250 1257 10.1016/j.neurobiolaging.2005.06.015 (Pubitemid 44088577)
75. Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons. M Lesort GV Johnson, Neuroscience 2000 99 2 305 316 10.1016/S0306-4522(00)00200-1 10938436
76. Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. M Lesort RS Jope GV Johnson, J Neurochem 1999 72 2 576 584 10.1046/j.1471-4159.1999.0720576.x 9930729
77. Peripheral hyperinsulinemia promotes tau phosphorylation in vivo. S Freude L Plum J Schnitker U Leeser M Udelhoven W Krone JC Bruning M Schubert, Diabetes 2005 54 12 3343 3348 10.2337/diabetes.54.12.3343 16306348
78. The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse. R Schechter D Beju KE Miller, Biochem Biophys Res Commun 2005 334 4 979 986 10.1016/j.bbrc.2005.07.001 16039605
79. Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. M Schubert DP Brazil DJ Burks JA Kushner J Ye CL Flint J Farhang-Fallah P Dikkes XM Warot C Rio, et al. J Neurosci 2003 23 18 7084 7092 12904469
80. Role for neuronal insulin resistance in neurodegenerative diseases. M Schubert D Gautam D Surjo K Ueki S Baudler D Schubert T Kondo J Alber N Galldiks E Kustermann, et al. Proc Natl Acad Sci USA 2004 101 9 3100 3105 10.1073/pnas.0308724101 14981233
81. The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's Disease. GM Cole SA Frautschy, Exp Gerontol 2007 42 1-2 10 21 10.1016/j.exger.2006.08.009 17049785
82. Role of insulin metabolism disturbances in the development of Alzheimer disease: mini review. B Sabayan F Foroughinia A Mowla A Borhanihaghighi, Am J Alzheimers Dis Other Demen 2008 23 2 192 199 10.1177/1533317507312623 18198237
83. Presenilin transgenic mice as models of Alzheimer's disease. GA Elder MA Gama Sosa R De Gasperi DL Dickstein PR Hof, Brain Struct Funct 2010 214 2-3 127 143 10.1007/s00429-009-0227-3 19921519
84. Skeletal and CNS defects in Presenilin-1-deficient mice. J Shen RT Bronson DF Chen W Xia DJ Selkoe S Tonegawa, Cell 1997 89 4 629 639 10.1016/S0092-8674(00)80244-5 9160754
85. Modification of human beta-globin locus PAC clones by homologous recombination in Escherichia coli. AM Ali Iman GP Patrinos M de Krom S Bottardi RJ Janssens E Katsantoni AWK Wai DJ Sherrat FG Grosveld, Nucleic Acids Research 2000 28 65 10.1093/nar/28.12.e65 10871388
86. Interactions of primary neuroepithelial progenitor and brain endothelial cells: distinct effect on neural progenitor maintenance and differentiation by soluble factors and direct contact. MA Gama Sosa R De Gasperi AB Rocher GM Perez K Simons DE Cruz PR Hof GA Elder, Cell Res 2007 17 7 619 626 10.1038/cr.2007.53 17593907
87. Cortical development in the presenilin-1 null mutant mouse fails after splitting of the preplate and is not due to a failure of reelin-dependent signaling. R De Gasperi MA Gama Sosa PH Wen J Li GM Perez T Curran GA Elder, Dev Dyn 2008 237 9 2405 2414 10.1002/dvdy.21661 18729224
88. Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide. S Dracheva N Patel DA Woo SM Marcus LJ Siever V Haroutunian, Mol Psychiatry 2008 13 11 1001 1010 10.1038/sj.mp.4002081 17848916
89. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. KJ Livak TD Schmittgen, Methods 2001 25 4 402 408 10.1006/meth.2001.1262 11846609